Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-090445
Filing Date
2025-06-26
Accepted
2025-06-26 16:36:04
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9043
  Complete submission text file 0000950170-25-090445.txt   10583
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O JAGUAR ANIMAL HEALTH, INC. 185 BERRY ST., SUITE 1300 SAN FRANCISCO CA 94107
Business Address
King Steven R. (Reporting) CIK: 0001622052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36714 | Film No.: 251080897